Stock listing
NASDAQ:LRMR Larimar Therapeutics, Inc. Stock
Home listing (NASDAQ) of Larimar Therapeutics, Inc.
Follow Larimar Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:LRMR
$2.47 USD -0.20 (-7.5%)
Close on Oct 30, 2026
- Day range
- $2.42 – $2.66 USDOct 30, 2026
- Volume
- 777,010 sharesOct 30, 2026
- Market cap
- $256.6M USDAt the close on Oct 30, 2026 · price × 103.9M shares outstanding
- 52-week range
- $1.92 – $6.42 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $4.25M USDMedian day 1.06M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:LRMR · Home | $2.47 USD | -0.20 (-7.5%) | 777,010 | $2.64 | $2.655 | $2.42 | $2.67 | Close on Oct 30, 2026 |
| Frankfurt:ZA71 | €1.94 EUR | -0.10 (-4.9%) | — | €1.94 | €1.94 | €1.94 | €2.04 | Close on Oct 27, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:LRMR · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.47 | -0.20 | -7.5% | $2.64 | $2.655 | $2.42 | 777,010 | |
| $2.67 | +0.13 | +5.1% | $2.57 | $2.73 | $2.558 | 1,026,963 | |
| $2.54 | +0.15 | +6.3% | $2.385 | $2.55 | $2.31 | 809,332 | |
| $2.39 | +0.15 | +6.7% | $2.25 | $2.41 | $2.21 | 1,203,992 | |
| $2.24 | -0.11 | -4.7% | $2.36 | $2.39 | $2.18 | 1,309,558 | |
| $2.35 | +0.08 | +3.5% | $2.27 | $2.37 | $2.22 | 1,144,000 | |
| $2.27 | -0.15 | -6.2% | $2.40 | $2.509 | $2.235 | 1,763,700 | |
| $2.42 | -0.02 | -0.8% | $2.40 | $2.54 | $2.39 | 1,512,900 | |
| $2.44 | +0.32 | +15.1% | $2.12 | $2.49 | $2.10 | 1,810,000 | |
| $2.12 | +0.135 | +6.8% | $1.99 | $2.175 | $1.96 | 1,231,300 | |
| $1.985 | -0.005 | -0.3% | $2.05 | $2.07 | $1.915 | 1,692,000 | |
| $1.99 | -0.10 | -4.8% | $2.09 | $2.115 | $1.95 | 6,174,400 | |
| $2.09 | -0.07 | -3.2% | $2.15 | $2.22 | $2.06 | 2,257,000 | |
| $2.16 | -0.37 | -14.6% | $2.53 | $2.53 | $2.13 | 2,565,100 | |
| $2.53 | -0.14 | -5.2% | $2.66 | $2.69 | $2.53 | 950,200 | |
| $2.67 | -0.03 | -1.1% | $2.68 | $2.74 | $2.62 | 867,600 | |
| $2.70 | -0.05 | -1.8% | $2.72 | $2.74 | $2.61 | 1,190,400 | |
| $2.75 | -0.03 | -1.1% | $2.77 | $2.835 | $2.72 | 718,000 | |
| $2.78 | -0.08 | -2.8% | $2.88 | $2.90 | $2.74 | 828,100 | |
| $2.86 | -0.10 | -3.4% | $2.96 | $3.04 | $2.775 | 886,000 | |
| $2.96 | -0.10 | -3.3% | $3.11 | $3.11 | $2.92 | 835,000 | |
| $3.06 | -0.135 | -4.2% | $3.20 | $3.20 | $3.04 | 858,300 | |
| $3.195 | +0.055 | +1.8% | $3.13 | $3.225 | $3.075 | 1,497,000 | |
| $3.14 | -0.03 | -0.9% | $3.13 | $3.20 | $3.115 | 1,041,600 | |
| $3.17 | +0.095 | +3.1% | $3.04 | $3.231 | $3.03 | 1,672,800 | |
| $3.075 | -0.245 | -7.4% | $3.32 | $3.34 | $3.02 | 3,046,500 | |
| $3.32 | -0.545 | -14.1% | $3.85 | $3.86 | $3.305 | 3,632,000 | |
| $3.865 | +0.045 | +1.2% | $3.82 | $3.90 | $3.71 | 2,718,600 | |
| $3.82 | -0.01 | -0.3% | $3.91 | $3.965 | $3.815 | 702,900 | |
| $3.83 | +0.04 | +1.1% | $3.84 | $3.885 | $3.78 | 578,000 | |
| $3.79 | -0.01 | -0.3% | $3.81 | $3.88 | $3.75 | 1,640,900 | |
| $3.80 | -0.13 | -3.3% | $3.93 | $4.12 | $3.80 | 1,195,800 | |
| $3.93 | +0.02 | +0.5% | $3.93 | $3.97 | $3.825 | 1,951,900 | |
| $3.91 | +0.13 | +3.4% | $3.86 | $3.94 | $3.70 | 856,600 | |
| $3.78 | -0.14 | -3.6% | $3.93 | $3.98 | $3.74 | 1,169,100 | |
| $3.92 | +0.07 | +1.8% | $3.91 | $4.07 | $3.85 | 2,127,200 | |
| $3.85 | -0.02 | -0.5% | $3.82 | $3.86 | $3.74 | 870,900 | |
| $3.87 | -0.205 | -5.0% | $4.03 | $4.17 | $3.83 | 977,400 | |
| $4.075 | +0.245 | +6.4% | $3.76 | $4.08 | $3.72 | 1,040,600 | |
| $3.83 | 0.00 | 0.0% | $3.82 | $3.85 | $3.79 | 391,900 | |
| $3.83 | -0.04 | -1.0% | $3.90 | $3.90 | $3.774 | 683,700 | |
| $3.87 | -0.07 | -1.8% | $3.96 | $4.075 | $3.822 | 515,300 | |
| $3.94 | +0.12 | +3.1% | $3.78 | $3.95 | $3.77 | 755,300 | |
| $3.82 | -0.19 | -4.7% | $3.98 | $4.00 | $3.81 | 1,065,500 | |
| $4.01 | -0.04 | -1.0% | $4.03 | $4.08 | $3.98 | 641,500 | |
| $4.05 | -0.12 | -2.9% | $4.16 | $4.16 | $4.02 | 672,900 | |
| $4.17 | +0.01 | +0.2% | $4.14 | $4.18 | $4.02 | 702,100 | |
| $4.16 | +0.11 | +2.7% | $4.08 | $4.235 | $4.08 | 1,082,141 | |
| $4.05 | -0.13 | -3.1% | $4.23 | $4.23 | $3.93 | 945,554 | |
| $4.18 | +0.02 | +0.5% | $4.20 | $4.21 | $4.085 | 699,400 | |
| $4.16 | -0.09 | -2.1% | $4.21 | $4.21 | $3.975 | 1,158,000 | |
| $4.25 | +0.19 | +4.7% | $4.19 | $4.34 | $4.17 | 1,232,000 | |
| $4.06 | -0.26 | -6.0% | $4.31 | $4.35 | $4.05 | 869,500 | |
| $4.32 | -0.04 | -0.9% | $4.33 | $4.42 | $4.30 | 882,700 | |
| $4.36 | +0.09 | +2.1% | $4.26 | $4.39 | $4.17 | 1,183,000 | |
| $4.27 | -0.10 | -2.3% | $4.38 | $4.465 | $4.23 | 1,502,800 | |
| $4.37 | +0.06 | +1.4% | $4.31 | $4.40 | $4.275 | 1,180,800 | |
| $4.31 | +0.30 | +7.5% | $4.04 | $4.385 | $4.02 | 1,655,941 | |
| $4.01 | -0.15 | -3.6% | $4.15 | $4.29 | $4.005 | 1,396,783 | |
| $4.16 | -0.04 | -1.0% | $4.24 | $4.28 | $4.08 | 631,100 | |
| $4.20 | +0.10 | +2.4% | $4.19 | $4.31 | $4.14 | 759,800 | |
| $4.10 | -0.01 | -0.2% | $4.11 | $4.29 | $4.075 | 1,281,100 | |
| $4.11 | +0.13 | +3.3% | $3.98 | $4.139 | $3.82 | 1,681,500 | |
| $3.98 | +0.16 | +4.2% | $3.83 | $4.00 | $3.74 | 793,600 | |
| $3.82 | -0.005 | -0.1% | $3.82 | $3.86 | $3.715 | 1,059,300 | |
| $3.825 | +0.195 | +5.4% | $3.65 | $3.895 | $3.60 | 1,033,100 |
- Ticker
- NASDAQ:LRMR
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Sep 29, 2026
Larimar Therapeutics Strengthens Executive Leadership with Appointment of John Harlow as President and Chief Operating Officer
Latest deck · Aug 4, 2026
Investor Presentation (August 2026)
Investor deck · 40 slides
Latest news
Larimar Therapeutics Strengthens Executive Leadership with Appointment of John Harlow as President and Chief Operating Officer
Sep 29, 2026
Closed $3.20 (+1.8%) on Sep 30, 2026
Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update
Aug 4, 2026
Closed $4.11 (+3.3%) on Aug 4, 2026
Larimar Therapeutics Reports Positive Open Label Data and Submission of First Module of Rolling BLA for Accelerated Approval of Nomlabofusp for Friedreich’s Ataxia
Jun 29, 2026
Closed $3.20 (-12.6%) on Jun 29, 2026
Larimar Therapeutics Announces Investor Event on the Nomlabofusp Program for Friedreich’s Ataxia
Jun 26, 2026
Closed $3.20 (-12.6%) on Jun 29, 2026
Larimar Therapeutics Reports First Quarter 2026 Financial and Business Update
May 14, 2026
Closed $3.89 (-5.1%) on May 14, 2026
Larimar Therapeutics Publishes Cross-Species Findings Supporting Skin as a Surrogate for the Measurement of Frataxin in Tissues Clinically Relevant to Friedreich’s Ataxia
Apr 30, 2026
Closed $3.94 (-3.0%) on May 1, 2026
Larimar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Mar 19, 2026
Closed $4.47 (+4.0%) on Mar 19, 2026
Larimar Therapeutics to Participate in Upcoming Investor Conferences in March
Mar 4, 2026
Closed $5.22 (-4.2%) on Mar 5, 2026
Larimar Therapeutics Announces Proposed $75 Million Underwritten Public Offering
Feb 25, 2026
Closed $5.52 (-7.2%) on Feb 26, 2026
Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering
Feb 25, 2026
Closed $5.95 (+61.2%) on Feb 25, 2026
Decks
Investor Presentation (August 2026)
Investor deck · 40 slides · Aug 4, 2026
Corporate Update (June 2026)
Corporate update · 26 slides · Jun 29, 2026
Investor Presentation (May 2026)
Investor deck · 54 slides · May 14, 2026
Investor Presentation (March 2026)
Investor deck · 54 slides · Mar 9, 2026
Larimar Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 13 in the last 12 months · 74 in all · newest Sep 29, 2026 · oldest 2020
- Decks
- 54 decks · latest Aug 4, 2026
Where Larimar Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:LRMR · Home listing · This page | NASDAQ | United States | USD |
| LS Exchange:A2P5PP | LS Exchange | Germany | EUR |
| gettex:ZA71 | gettex | Germany | EUR |
| BOATS:LRMR | BOATS | United States | USD |
| Lang & Schwarz:A2P5PP | Lang & Schwarz | Germany | EUR |
| Tradegate:ZA71 | Tradegate | Germany | EUR |
| Dusseldorf:ZA71 | Dusseldorf | Germany | EUR |
| Frankfurt:ZA71 | Frankfurt | Germany | EUR |
| Stuttgart:ZA71 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Larimar Therapeutics, Inc.